Log in

Soluble expression and purification of Brucella cell surface protein (BCSP31) of Brucella melitensis and preparation of anti-BCSP31 monoclonal antibodies

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Brucella cell surface protein (BCSP31) is potentially useful for diagnosing brucellosis. We aimed to establish a monoclonal antibody (MAb) against Brucella melitensis BCSP31 and to investigate its distribution in diagnosis. Soluble recombinant BCSP31 was successfully expressed and purified. Two MAbs (1F1 and 1E5) against B. melitensis BCSP31, effective in detecting both recombinant and cellular proteins, were obtained and characterized. The MAbs did not react with Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Mycobacterium tuberculosis, or Bacillus aeruginosus, but strongly reacted with BCSP31 and B. melitensis by ELISA and Western blot analysis. We also tested different Brucella species and brucellosis using the prepared anti-BCSP31 MAbs. BCSP31 and anti-BCSP31 MAbs may play important roles in future research in diagnosing brucellosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Akdeniz H, Irmak H, Anlar O et al (1998) Central nervous system brucellosis: presentation, diagnosis and treatment. J Infect 36:297–301

    Article  PubMed  CAS  Google Scholar 

  2. Franco MP, Mulder M, Gilman RH et al (2007) Human brucellosis. Lancet Infect Dis 7:775–786

    Article  PubMed  CAS  Google Scholar 

  3. World Health Organization (1997) Fact Sheet N173. World Health Organization, Geneva

    Google Scholar 

  4. Shang DQ (2004) Research on Brucella spp. Chin J Ctrl Endem Dis 19:204–213 (in Chinese)

    Google Scholar 

  5. Pappas G, Akritidis N, Bosilkovski M et al (2005) Brucellosis. N Engl J Med 352:2325–2336

    Article  PubMed  CAS  Google Scholar 

  6. Young EJ (1991) Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis 13:359–372

    Article  PubMed  CAS  Google Scholar 

  7. Vizcaino N, Cloekaert A, Zygmunt MS et al (1999) Molecular characterization of a Brucella species large DNA fragment deleted in B. abortus strains: evidence for a locus involved in the synthesis of a polysaccharide. Infect Immun 67:2700–2712

    PubMed  CAS  Google Scholar 

  8. Ding JB, Mao KR, Chen XY et al (2006) Sequence analysis on BCSP31 genes of 8 different Brucella species. Chin J Vet Drug 40:13–16 (in Chinese)

    Google Scholar 

  9. Li P, Luo DY, Gao YH et al (2006) Construction of the recombinant expression plasmid BCSP31/pVAXl of Brucella and evaluation of its immuno-protective effect. Chin J Zoonoses 22:493–496 (in Chinese)

    CAS  Google Scholar 

  10. Davis DS, Elzer PH (2002) Brucella vaccines in wildlife. Vet Microbiol 90:533–544

    Article  PubMed  CAS  Google Scholar 

  11. Bricker BJ, Tabatabai LB, Deyoe BL et al (1988) Conservation of antigenicity in a 31-kDa Brucella protein. Vet Microbiol 18:313–325

    Article  PubMed  CAS  Google Scholar 

  12. Hasanjani Roushan MR, Mohrez M, Smailnejad Gangi SM (2004) Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect 132:1109–1114

    Article  PubMed  CAS  Google Scholar 

  13. Madkour MM (2001) Difficulties in diagnosis and treatment. In: Madkour MM (ed) Brucellosis. Springer, Germany, pp 221–231

    Google Scholar 

  14. Yumuk Z, Afacan G, Caliskan S (2007) Relevance of autoantibody detection to the rapid diagnosis of brucellosis. Diagn Microbiol Infect Dis 58:271–273

    Article  PubMed  CAS  Google Scholar 

  15. Cloeckaert A, Vizcaíno N, Paquet JY et al (2002) Major outer membrane proteins of Brucella spp.: past, present and future. Vet Microbiol 20:229–247

    Article  Google Scholar 

  16. Hoffmann F, Heuvel J, Zidek N et al (2004) Minimizing inclusion body formation during recombinant protein production in Escherichia coli at bench and pilot plant scale. Enzyme Microb Tech 34:235–241

    Article  CAS  Google Scholar 

  17. Thakur MK, Ghosh S (2010) GST-tagged mouse estrogen receptor a-transactivation domain fusion protein is specifically degraded during its over-expression in E. coli and purification. Mol Biol Rep 37:1335–1340

    Article  PubMed  CAS  Google Scholar 

  18. Hayashi K, Kojima C (2008) pCold-GST vector: a novel cold-shock vector containing GST tag for soluble protein production. Protein Express Purif 62:120–127

    Article  Google Scholar 

  19. Cai X, Wang JF, Wang YY et al (2010) Expression, purification and characterization of recombinant human interleukin-22 in Pichia pastoris. Mol Biol Rep 37:2609–2613

    Article  PubMed  CAS  Google Scholar 

  20. Song JP, Chen WT, Lu ZS et al (2011) Soluble expression, purification, and characterization of recombinant human flotillin-2 (reggie-1) in Escherichia coli. Mol Biol Rep. doi:10.1007/s11033-010-0335-4

  21. Liu SX, Fu ZP, Mu RM et al (2010) Expression and characterization of Momordica Chanrantia anti-hyperglycaemic peptide in Escherichia coli. Mol Biol Rep 37:1781–1786

    Article  PubMed  CAS  Google Scholar 

  22. Cabrita LD, Bottomley SP (2004) Protein expression and refolding—a practical guide to getting the most out of inclusion bodies. Biotechnol Annu Rev 10:31–50

    Article  PubMed  CAS  Google Scholar 

  23. Tabatabai LB, Hennager SG (1994) Cattle serologically positive for Brucella abortus have antibodies to B. abortus Cu-Zn superoxide dismutase. Clin Diagn Lab Immunol 1:506–510

    PubMed  CAS  Google Scholar 

  24. Kumar G, Rathore G, Sengupta U et al (2010) Production of monoclonal antibodies specific to major outer membrane protein of Edwardsiella tarda. Comp Immunol Microbiol Infect Dis 33:133–144

    Article  PubMed  Google Scholar 

  25. Zhang YQ, Li KN, Cui JH et al (2011) Abnormal expression of NRF-2a in hepatocellular carcinoma identified with a newly prepared monoclonal antibody against human NRF-2a protein. Mol Biol Rep. doi:10.1007/s11033-010-9976-6

  26. Corbel MJ (1997) Brucellosis: an overview. Emerg Infect Dis 3:213–221

    Article  PubMed  CAS  Google Scholar 

  27. Xu WM, ** FZ, Su TK et al (2008) A dot-immunogold filtration assay to detect brucellosis in different areas. Chin Prev Med 9:681–682 (in Chinese)

    Google Scholar 

Download references

Acknowledgments

We thank Professor Wenyu Ma, and Dr. Jun** Ren for their advice and assistance. Ailin Fan (**jng Hospital, **’an, China) and Jie Zhang (Center of Experiments, The Fourth Military Medical University) generously supplied the bacterial strains. This work was supported by grants from the Military Medical Science and Technique Foundation (No. 06G091) and National Natural Science Foundation of China (No. 30901281).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Wen Tao Bai or Zhi Kai Xu.

Additional information

Lei Zhang and **ng An Wu contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 39 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, L., Wu, X.A., Zhang, F.L. et al. Soluble expression and purification of Brucella cell surface protein (BCSP31) of Brucella melitensis and preparation of anti-BCSP31 monoclonal antibodies. Mol Biol Rep 39, 431–438 (2012). https://doi.org/10.1007/s11033-011-0755-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-011-0755-9

Keywords

Navigation